ⓘ Placulumab

                                     

ⓘ Placulumab

Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.

This drug was developed by Teva pharmaceutical industries, Inc. As of 2012, development placulumab was discontinued.

                                     
  • Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors: Etanercept Lenercept Onercept Pegsunercept Enzyme inhibitors:
  • Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors: Etanercept Lenercept Onercept Pegsunercept Enzyme inhibitors:
  • Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors: Etanercept Lenercept Onercept Pegsunercept Enzyme inhibitors:
  • Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors: Etanercept Lenercept Onercept Pegsunercept Enzyme inhibitors:
  • Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors: Etanercept Lenercept Onercept Pegsunercept Enzyme inhibitors:
  • Certolizumab pegol Golimumab Infliximab Nerelimomab Ozoralizumab Remtolumab Placulumab Decoy receptors: Etanercept Lenercept Onercept Pegsunercept Enzyme inhibitors: